Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study

Sodium-glucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP-1RA) are novel anti-diabetic drugs whose glucose-lowering effect and cardiovascular and renal benefits were evidenced in clinical trials. We investigated the real-world efficacy and safety of the comb...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hwi Seung, Yoon, Taekwan, Jung, Chang Hee, Park, Joong-Yeol, Lee, Woo Je
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353570/
https://www.ncbi.nlm.nih.gov/pubmed/34743486
http://dx.doi.org/10.4093/dmj.2021.0232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353570/
https://www.ncbi.nlm.nih.gov/pubmed/34743486
http://dx.doi.org/10.4093/dmj.2021.0232

Ejemplares similares